E-LIB Suche - Ergebnisse für: Sonja Zweegman

1

Ixazomib-Thalidomide-low dose dexamethasone induction follo..:

Sonja Zweegman ; Claudia A.M. Stege ; Einar Haukas...
Haematologica. 105 (2020) 12 - p. 2879-2882 , 2020

Link: https://doi.org/10.3324/..

2

Bortezomib, thalidomide, and dexamethasone with or without ..:

Moreau, Philippe ; Hulin, Cyrille ; Perrot, Aurore...
The Lancet Oncology. , 2024

Link: https://doi.org/10.1016/..

3

The Phase 2 Cartitude-2 Trial: Updated Efficacy and Safety ..:

Hillengass, Jens ; Cohen, Adam D. ; Agha, Mounzer...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S36-S37 , 2024

Link: https://doi.org/10.1016/..

4

HOVON 104, long‐term follow‐up of bortezomib‐dexamethasone ..:

Minnema, Monique C. ; Nasserinejad, Kazem ; Hegenbart, Ute...
eJHaem. , 2024

Link: https://doi.org/10.1002/..

5

Assessing frailty in myeloma: The pursuit of simplicity may..:

Groen, Kazimierz ; Smits, Febe ; Nasserinejad, Kazem...
HemaSphere. 8 (2024) 7 - p. , 2024

Link: https://doi.org/10.1002/..

6

P329: HIGH IMMUNOPROTEASOME ACTIVITY AS NOVEL INDICATOR FOR..:

Roeten, Margot ; van Dijk, Suzanne ; van Meerloo, Johan...
HemaSphere. 7 (2023) S3 - p. e81299a0 , 2023

Link: https://doi.org/10.1097/..

7

Limited efficacy of APRIL CAR in patients with multiple mye..:

Lee, Lydia ; Lim, Wen Chean ; Galas-Filipowicz, Daria...
Journal for ImmunoTherapy of Cancer. 11 (2023) 6 - p. e006699 , 2023

Link: https://doi.org/10.1136/..

8

T-cell redirecting bispecific and trispecific antibodies in..:

van de Donk, Niels W.C.J. ; O'Neill, Chloe ; de Ruijter, Maaike E.M...
Current Opinion in Oncology. 35 (2023) 6 - p. 601-611 , 2023

Link: https://doi.org/10.1097/..

9

Predictors of early morbidity and mortality in newly diagno..:

Mai, Elias K. ; Hielscher, Thomas ; Bertsch, Uta...
Leukemia. 38 (2023) 3 - p. 640-647 , 2023

Link: https://doi.org/10.1038/..

10

Management of patients with multiple myeloma and COVID-19 i..:

Terpos, Evangelos ; Musto, Pellegrino ; Engelhardt, Monika...
Leukemia. 37 (2023) 6 - p. 1175-1185 , 2023

Link: https://doi.org/10.1038/..

11

P1506: TECLISTAMAB REDUCES POLYCLONAL IMMUNOGLOBULIN LEVELS..:

Frerichs, Kristine ; Verkleij, Christie ; Mateos, Maria-Victoria...
HemaSphere. 7 (2023) S3 - p. e5193345 , 2023

Link: https://doi.org/10.1097/..

12

P877: IXAZOMIB DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN IN..:

Groen, Kaz ; Stege, Claudia ; Nasserinejad, Kazem...
HemaSphere. 7 (2023) S3 - p. e25266f8 , 2023

Link: https://doi.org/10.1097/..

13

A bispecific T cell engager recruits both type 1 NKT and Vγ..:

Lameris, Roeland ; Ruben, Jurjen M. ; Iglesias-Guimarais, Victoria...
Cell Reports Medicine. 4 (2023) 3 - p. 100961 , 2023

Link: https://doi.org/10.1016/..

14

NK Cell Phenotype Is Associated With Response and Resistanc..:

Verkleij, Christie P.M. ; Frerichs, Kristine A. ; Broekmans, Marloes E.C....
HemaSphere. 7 (2023) 5 - p. e881 , 2023

Link: https://doi.org/10.1097/..

15

Ixazomib, daratumumab and low-dose dexamethasone in interme..:

Groen, Kaz ; Stege, Claudia A.M. ; Nasserinejad, Kazem...
eClinicalMedicine. 63 (2023) - p. 102167 , 2023

Link: https://doi.org/10.1016/..